Global Transplantation Preservation Solutions Market, By Technique (Static Cold Storage, Hypothermic Perfusion Preservation and Other), Preservation Solutions (Viaspan, Custodiol HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem (HBS) Solution, siRNA Transplant Solutions and Others), Organ Type (Kidneys, Lung, Liver, Heart and Others) – Industry Trends and Forecast to 2030.
Transplantation Preservation Solutions Market Analysis and Size
Transplantation preservation solutions are those solutions that are used to preserve the organs. The transplantation preservation solutions prevent the organs from getting decayed and preserve them before they are ultimately used for transplantation. Not just that, the transplantation preservation solutions are used to maintain the temperature of the organs. Upsurge in the kidney failure cases owing to the increased consumption of alcohol is one of the major factors inducing growth in the global transplantation preservation solutions market value.
Data Bridge Market Research analyses that the global transplantation preservation solutions market which was USD 244.12 million in 2022, is expected to reach USD 341.12 million by 2030, and is expected to undergo a CAGR of 6.0% during the forecast period of 2023 to 2030. “Static Cold Storage” dominates the technique segment of the global transplantation preservation solutions market due to rising organ transplantation rates. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Transplantation Preservation Solutions Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technique (Static Cold Storage, Hypothermic Perfusion Preservation and Other), Preservation Solutions (Viaspan, Custodiol HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem (HBS) Solution, siRNA Transplant Solutions and Others), Organ Type (Kidneys, Lung, Liver, Heart and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Transplantation preservation solutions are referred to as the solutions used to store organs and minimize tissue damage, particularly while awaiting implantation. These are used to protect organs prior to transplantation because organs in the outer environment often collapse once removed from the human body.
Global Transplantation Preservation Solutions Market Dynamics
Drivers
- Rising Organ Transplantation Rates
The increasing global demand for organ transplantation is a major driver of the global transplantation preservation solutions market. This surge in transplantation activity can be attributed to several factors. First, the prevalence of chronic diseases and organ failure, such as kidney and liver failure, continues to rise. Additionally, advancements in transplantation procedures have expanded the pool of potential transplant recipients. As a result, there is a growing need for effective preservation solutions to maximize the success of these life-saving procedures. Organ transplantation has become the preferred treatment for many end-stage organ diseases. Patients with conditions such as end-stage renal disease, cirrhosis, or heart failure rely on transplantation as their best hope for improved quality of life and prolonged survival. Consequently, the demand for transplantation preservation solutions is closely tied to the increasing number of transplant procedures performed globally.
- Technological Advancements in Transplantation Preservation Solutions
Ongoing advancements in preservation techniques and technologies represent a pivotal driver of market growth. These innovations are designed to optimize the preservation of organs and tissues from donors to recipients, ensuring their viability during the critical period between retrieval and transplantation. Preservation solutions have evolved significantly, with improved formulations that better maintain organ integrity and function. These solutions are tailored to specific organs, such as the heart, kidney, liver, and lungs, optimizing their suitability for transplantation. For example, advanced cold storage solutions and perfusion systems enable longer preservation times and better preservation of organ quality.
- Growing Awareness and Education
Increasing awareness about the importance of organ donation and transplantation, coupled with educational initiatives, has resulted in greater public support for transplantation. The general public's understanding of the significance of organ transplantation in saving lives and improving the quality of life has grown significantly. Educational campaigns and advocacy organizations play a crucial role in dispelling myths and misconceptions about organ donation. These efforts highlight the impact of transplantation on recipients and their families, fostering a positive attitude toward organ donation.
Opportunities
- Telemedicine and Remote Monitoring
The adoption of telemedicine and remote monitoring technologies can enhance the quality of transplantation procedures and create opportunities for innovative preservation solutions. Remote monitoring of organ conditions during transportation can be facilitated through technology. Real-time monitoring and assessment of organ function can improve decision-making and reduce the risk of complications during transplantation. The integration of telemedicine into transplantation protocols represents a promising avenue for market growth.
- Emerging and Markets Expansion
Expanding access to transplantation services in emerging markets and regions with previously limited access presents substantial growth opportunities. Collaborations between healthcare organizations, transplant centers, and governmental bodies can facilitate the establishment of transplantation programs. Efforts to improve infrastructure, training, and healthcare systems can create new markets for transplantation preservation solutions. As these regions develop their transplantation capabilities, the demand for preservation solutions is expected to increase.
Restraints/Challenges
- Ethical and Legal Considerations
Ethical considerations surrounding organ transplantation can pose challenges for the global transplantation preservation solutions market. Issues related to informed consent, organ allocation, donor anonymity, and the ethical implications of new transplantation technologies require careful consideration. Ethical dilemmas can affect organ procurement and transplantation processes, leading to delays and controversies. Balancing ethical principles with practical considerations is an ongoing challenge that healthcare professionals, policymakers, and ethicists grapple with. Additionally, legal frameworks surrounding organ transplantation and preservation can vary widely from country to country, adding another layer of complexity. Adhering to these legal requirements while navigating ethical considerations is critical for the successful functioning of the transplantation system.
-
Logistics and Transportation
The safe transportation of preserved organs over long distances is a critical but challenging aspect of organ transplantation. Maintaining optimal conditions, including temperature and oxygenation, is essential for preserving organ viability. Logistics and transportation challenges can arise due to factors such as the remoteness of donor and recipient locations, adverse weather conditions, and the need for rapid transportation. Minimizing transit times while ensuring organ safety and quality remains a logistical puzzle.
This global transplantation preservation solutions market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global transplantation preservation solutions market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2023, Transplant surgeons at MedStar Georgetown University Hospital in the Washington Metropolitan area of the United States successfully utilized a new FDA-approved technology, the OrganOx metra, which simulates connecting a liver to its recipient, allowing the donated liver to be preserved for up to 12 hours before being transplanted into the recipient
Global Transplantation Preservation Solutions Market Scope
The global transplantation preservation solutions market is segmented on the basis of technique, preservation solutions and organ type. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technique
- Static Cold Storage
- Hypothermic Perfusion Preservation
- Other
Preservation Solutions
- Viaspan
- Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
- Renograf
- Hypothermosol
- Perfadex
- Lifor
- Human bioSystem (HBS) Solution
- siRNA Transplant Solutions
- Others
Organ Type
- Kidneys
- Lung
- Liver
- Heart
- Others
Global Transplantation Preservation Solutions Market Regional Analysis/Insights
The global transplantation preservation solutions market is analysed and market size insights and trends are provided by country, technique, preservation solutions and organ type as referenced above.
The countries covered in the global transplantation preservation solutions market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global transplantation preservation solutions market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global transplantation preservation solutions market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The global transplantation preservation solutions market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global transplantation preservation solutions market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global transplantation preservation solutions market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Transplantation Preservation Solutions Market Share Analysis
The global transplantation preservation solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global transplantation preservation solutions market.
Some of the major players operating in the global transplantation preservation solutions market are:
- GSK plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Astrazeneca (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sanofi (U.S.)
- Amgen Inc. (U.S.)
- Daiichi Sankyo Company Limited (Japan)
- AB Sciences (France)
- Eisai Co., Ltd (Japan)
- Genentech Inc. (U.S)
- Merck & Co., Inc. (U.S.)
SKU-